OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Our product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD).
industry news
company news
-------------------------------------------
--------------------------------------------
OphthalmoPharma will present the latest developments of its pipeline at the occasion of the:
BioEurope Spring Conference on April 7 to 9 2008 in Madrid, Spain.
Rodman & Renshaw 5th Annual Global Healthcare Conference on May 19-20 2008, in Monte Carlo, Monaco.
If you would like to arrange a meeting with the OphthalmoPharma team at any of these conferences, please click here
July 3rd 2008
OphthalmoPharma is pleased to announce that Motti Geron has joined the Company as Projects Manager. His outstanding operational experience will be of particular value to the Company. Motti will be in charge of the projects management and coordination with top management and external partners. read more
May 1 st 2008
OphthalmoPharma drug delivery approach is described in the May 1 2008 (Vol. 28, No. 9) edition of GEN, Genetics Engineering and Biotechnology News. read article
beecomb powered by beecom - beecomb the Professional Swiss CMS
